BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4397540)

  • 1. Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect.
    Azarnoff DL; Svoboda DJ
    Arch Int Pharmacodyn Ther; 1969 Oct; 181(2):386-93. PubMed ID: 4397540
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of selected hypolipidemic drugs on cell ultrastructure.
    Svoboda DJ; Azarnoff DL
    Fed Proc; 1971; 30(3):841-7. PubMed ID: 5575296
    [No Abstract]   [Full Text] [Related]  

  • 3. Proliferation of microbodies and synthesis of catalase in rat liver. Induction in tumor-bearing host by CPIB.
    Reddy J; Svoboda D
    Am J Pathol; 1971 Apr; 63(1):99-108. PubMed ID: 4323477
    [No Abstract]   [Full Text] [Related]  

  • 4. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
    Reddy J; Svoboda D; Azarnoff D
    Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.
    Leighton F; Coloma L; Koenig C
    J Cell Biol; 1975 Nov; 67(2PT.1):281-309. PubMed ID: 406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of clofibrate (Atromid S) on the thyroxine-binding capacity of thyroxine-binding globulin and free thyroxine.
    McKerron CG; Scott RL; Asper SP; Levy RI
    J Clin Endocrinol Metab; 1969 Jul; 29(7):957-61. PubMed ID: 4978385
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on peroxisomes. V. Effect of ethyl p-chlorophenoxyisobutyrate on the centrifugal behavior of rat liver peroxisomes.
    Hayashi H; Suga T; Ninobe S
    J Biochem; 1975 Jun; 77(6):1199-204. PubMed ID: 5399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth and liver glycerophosphate dehydrogenase response to thyroxine and p-chlorophenoxyisobutyrate.
    Richert DA; Westerfeld WW
    Endocrinology; 1970 Dec; 87(6):1274-81. PubMed ID: 5529883
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of citrate and aminotriazole on matrical plates induced in hepatic microbodies.
    Gotoh M; Griffin C; Hruban Z
    Virchows Arch B Cell Pathol; 1975; 17(4):279-94. PubMed ID: 166481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of clofibrate on acetyl-CoA carboxylase activity in hepatocytes.
    Harkins JB; Yates RD
    Z Zellforsch Mikrosk Anat; 1971; 119(3):321-5. PubMed ID: 5569050
    [No Abstract]   [Full Text] [Related]  

  • 12. Increase in hepatic carnitine acetyltransferase activity associated with peroxisomal (microbody) proliferation induced by the hypolipidemic drugs clofibrate, nafenopin, and methyl clofenapate.
    Moody DE; Reddy JK
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):501-10. PubMed ID: 4445568
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
    White LW
    J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
    [No Abstract]   [Full Text] [Related]  

  • 14. Rat liver peroxisomes. I. New peroxisome population induced by thyroid hormones in the liver of male rats.
    Just WW; Hartl FU; Schimassek H
    Eur J Cell Biol; 1982 Feb; 26(2):249-54. PubMed ID: 6121707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New observations on microbodies. A cytochemical study on CPIB-treated rat liver.
    Legg PG; Wood RL
    J Cell Biol; 1970 Apr; 45(1):118-29. PubMed ID: 5458991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid lowering influence of ethyl p-chlorophenoxyisobutyrate in liver of rats fed high fat diets.
    Kokatnur MG; Malcom GT
    Metabolism; 1970 Feb; 19(2):120-8. PubMed ID: 5410942
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of some hypocholesterolemic agents on hepatic ulrastructure and microbody enzymes.
    Hruban Z; Mochizuki Y; Goto M; Slesers A; Chou SH
    Lab Invest; 1974 Apr; 30(4):474-85. PubMed ID: 4150963
    [No Abstract]   [Full Text] [Related]  

  • 18. Peroxisomal beta-oxidation and catalase activities in fetal rat liver: effect of maternal treatment with clofibrate.
    Cibelli A; Stefanini S; Ceru MP
    Cell Mol Biol; 1988; 34(2):191-205. PubMed ID: 3378247
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of clofibrate on plasma lipids of rat and rabbit.
    Byers SO; Friedman M
    Atherosclerosis; 1970; 11(3):373-82. PubMed ID: 5433083
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic effect of two hypolipidemic drugs in rats.
    Magnusson G; Magnusson O
    Exp Pathol (Jena); 1977; 13(2-3):180-7. PubMed ID: 913535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.